CELL AND GENE THERAPY INSIGHTS

Induced pluripotent stem cells (iPSCs)

March 2025
Induced pluripotent stem cells (iPSCs)

Commentary

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald
11 March
Read

Interview

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Kim Raineri
28 February
Read

Webinars

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al.
23 April
in 25
Days
Register